CN114585356A - 预防或治疗与vegfr和/或vegf被抑制相关疾病的方法 - Google Patents
预防或治疗与vegfr和/或vegf被抑制相关疾病的方法 Download PDFInfo
- Publication number
- CN114585356A CN114585356A CN202080072302.3A CN202080072302A CN114585356A CN 114585356 A CN114585356 A CN 114585356A CN 202080072302 A CN202080072302 A CN 202080072302A CN 114585356 A CN114585356 A CN 114585356A
- Authority
- CN
- China
- Prior art keywords
- inhibitor
- vegfr
- vegf
- administration
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
涉及硝基化合物在制备药物中的新用途,所述药物用于预防或治疗与施用VEGFR抑制剂和/或VEGF抑制剂相关的疾病或病症。还提供预防或者治疗与施用VEGFR抑制剂和/或VEGF抑制剂相关的包含本申请所述化合物的药物组合或试剂盒。还提供了一种预防或治疗疾病或病症的方法,其包括监测被施用VEGFR抑制剂和/或VEGF抑制剂的受试者的一种或多种皮肤组织、五官和/或胃肠道特征,当所述监测显示到疾病或病症时,向所述受试者施用所述的化合物。
Description
PCT国内申请,说明书已公开。
Claims (71)
- PCT国内申请,权利要求书已公开。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910983799 | 2019-10-16 | ||
CN2019109837993 | 2019-10-16 | ||
PCT/CN2020/120916 WO2021073535A1 (zh) | 2019-10-16 | 2020-10-14 | 预防或治疗与vegfr和/或vegf被抑制相关疾病的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114585356A true CN114585356A (zh) | 2022-06-03 |
Family
ID=75538459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202080072302.3A Pending CN114585356A (zh) | 2019-10-16 | 2020-10-14 | 预防或治疗与vegfr和/或vegf被抑制相关疾病的方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN114585356A (zh) |
WO (1) | WO2021073535A1 (zh) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0425658D0 (en) * | 2004-11-22 | 2004-12-22 | Stanford Rook Ltd | Immunotherapeutic agent |
EP2805730A1 (en) * | 2013-05-21 | 2014-11-26 | Bergen Teknologioverforing AS | Nitric oxide donor for the treatment of chronic fatigue syndrome |
WO2014197847A1 (en) * | 2013-06-07 | 2014-12-11 | The Regents Of The University Of California | Methods and systems of treating wounds |
CA3097067A1 (en) * | 2018-04-16 | 2019-10-24 | Onquality Pharmaceuticals China Ltd. | Method for preventing or treating side effects of cancer therapy |
-
2020
- 2020-10-14 CN CN202080072302.3A patent/CN114585356A/zh active Pending
- 2020-10-14 WO PCT/CN2020/120916 patent/WO2021073535A1/zh active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2021073535A1 (zh) | 2021-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7262508B2 (ja) | 癌を治療するための方法 | |
JP7520366B2 (ja) | 腫瘍療法の副作用の予防または治療方法 | |
JP7445893B2 (ja) | ヒトにおける固形腫瘍の処置のためのC.novyi | |
BR112019024135A2 (pt) | Terapias de combinação para o tratamento de câncer | |
KR20200067164A (ko) | 조합 요법 및 그의 용도 | |
ES2641864T3 (es) | Terapia de combinación de un inhibidor de MEK y un inhibidor de IGF1R | |
WO2022143628A1 (zh) | 预防或治疗抗肿瘤剂相关疾病或病症的方法 | |
MX2014010591A (es) | Terapia combinada para el tratamiento de cancer de ovario. | |
CN112672739A (zh) | 治疗癌症的方法 | |
US10583111B2 (en) | Method for preventing or treating diseases associated with the inhibition of EGFR | |
RU2764175C1 (ru) | Бифункциональные композиции для лечения рака | |
JP7516336B2 (ja) | チロシンキナーゼ阻害剤と併用してegf/egfr経路を抑制する方法および組成物 | |
CN116669765A (zh) | 预防或治疗egfr功能异常相关的副作用的方法 | |
US10457740B1 (en) | Methods and compositions for treating cancer using P2RX2 inhibitors | |
CN114585356A (zh) | 预防或治疗与vegfr和/或vegf被抑制相关疾病的方法 | |
WO2023142996A1 (zh) | 预防或治疗与抗肿瘤剂相关的疾病或病症的方法 | |
CN116211789A (zh) | 组合物及其用途 | |
RU2782033C2 (ru) | Способ профилактики или лечения побочного эффекта опухолевой терапии | |
US20220363776A1 (en) | Methods and pharmaceutical composition for the treatment of ovarian cancer, breast cancer or pancreatic cancer | |
WO2024102968A1 (en) | Uses of ep2/ep4 antagonist compounds for treating familial adenomatous polyposis (fap) | |
WO2024019976A1 (en) | Methods for treating cancer including glatiramer acetate and immune checkpoint inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40069551 Country of ref document: HK |